glp-1 agonists glp-1_analogs [TUSOM Holding GLP-1 Agonists Prior to
Description
Nevertheless, the overall drug exposure was not considered clinically significant
Medicare is already spending billions on drugs like Ozempic, and Biden recently proposed expanding access to obesity treatments.
Some studies, though not conclusive, predict that tirzepatide may in fact be more potent than GLP-1 RAs at reducing weight
FDA updates rules on compounded GLP-1 drugs, impacting patients and providers
The reason
Earlier this year, Blue Cross Blue Shield said five GLP-1 drugs now account for nearly 20% of its pharmacy spend.
